MARKET

EWTX

EWTX

Edgewise Therapeutics, Inc.
NASDAQ
33.09
-0.92
-2.71%
After Hours: 33.10 +0.01 +0.03% 19:46 05/15 EDT
OPEN
33.81
PREV CLOSE
34.01
HIGH
33.95
LOW
32.76
VOLUME
989.17K
TURNOVER
--
52 WEEK HIGH
39.96
52 WEEK LOW
12.15
MARKET CAP
3.56B
P/E (TTM)
-19.9253
1D
5D
1M
3M
1Y
5Y
1D
Trump Trade: Trump to suspend tariff-rate quotas on beef imports
TipRanks · 4d ago
Goldman Sachs Sticks to Its Hold Rating for Edgewise Therapeutics (EWTX)
TipRanks · 4d ago
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2026
PR Newswire · 4d ago
Trump approves plan to fire FDA head Marty Makary, CBS reports
TipRanks · 5d ago
Weekly Report: what happened at EWTX last week (0504-0508)?
Weekly Report · 5d ago
Stifel Nicolaus Remains a Hold on Edgewise Therapeutics (EWTX)
TipRanks · 6d ago
Trump plans to fire FDA commissioner Marty Makary, WSJ reports
TipRanks · 05/08 19:05
Edgewise Therapeutics (EWTX) Receives a Buy from Evercore ISI
TipRanks · 05/08 16:55
More
About EWTX
Edgewise Therapeutics, Inc. is a muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s lead product candidate, sevasemten (EDG-5506), is an orally administered skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. Its EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, which is in Phase II clinical development. The Company is using its proprietary drug discovery platform to develop a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a broad array of serious muscle disorders. Its platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue.

Webull offers Edgewise Therapeutics Inc stock information, including NASDAQ: EWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EWTX stock methods without spending real money on the virtual paper trading platform.